https://news.medxy.ai/zh/bradycardia-during-throat-microlaryngoscopy/Medxy AIzh2026-08-23T09:30:19-07:00悬吊式显微喉镜手术中的术中心动过缓：发生率、危险因素与血管迷走事件处理 https://news.medxy.ai/ja/microlaryngoscopy-bradycardia/Medxy AIja2026-08-23T09:30:05-07:00懸垂式顕微喉頭鏡下手術中の術中徐脈：発生頻度・危険因子・血管迷走神経イベントへの対応 https://news.medxy.ai/vi/bradycardia-surgery/Medxy AIvi2026-08-23T09:29:48-07:00Nhịp tim chậm trong mổ khi phẫu thuật nội soi thanh quản treo: Tỷ lệ mắc, yếu tố nguy cơ và xử trí các biến cố phế vị – thần kinh mạch máu https://news.medxy.ai/zh/personalized-prediction/Medxy AIzh2026-08-23T09:28:39-07:00从二元判断到个体化预测：机器学习概率评分助力人工耳蜗植入候选筛查 https://news.medxy.ai/ja/personalized-cochlear-implant-prediction/Medxy AIja2026-08-23T09:28:22-07:00二分法から個別化へ：機械学習による確率スコアで蝸牛インプラント適応判定を高度化 https://news.medxy.ai/vi/binary-to-personalization/Medxy AIvi2026-08-23T09:28:04-07:00Từ nhị phân đến cá thể hóa: Nâng cao sàng lọc ứng viên cấy ốc tai điện tử bằng điểm xác suất machine learning https://news.medxy.ai/zh/66513-2/Medxy AIzh2026-08-23T09:26:36-07:00 https://news.medxy.ai/ja/cml-survivor-health/Medxy AIja2026-08-23T09:26:17-07:00TKI治療CML生存者の健康障害：BMT生存者・非がん対照との比較からみる臨床レビュー https://news.medxy.ai/vi/66511-2/Medxy AIvi2026-08-23T09:25:53-07:00 https://news.medxy.ai/zh/map-pattern-atrophy-amt/Medxy AIzh2026-08-23T09:23:48-07:00AMD中的地图样萎缩新分型：生长模式与临床意义 https://news.medxy.ai/ja/66507-2/Medxy AIja2026-08-23T09:23:31-07:00 https://news.medxy.ai/vi/amd-geographic-atrophy/Medxy AIvi2026-08-23T09:23:11-07:00Trong AMD, ba kiểu hình teo địa lý cho thấy các mô hình tăng trưởng và ý nghĩa lâm sàng khác nhau https://news.medxy.ai/zh/patient-centered-education/Medxy AIzh2026-08-23T09:21:43-07:00提升肺功能检查中的患者体验与理解：一项关于以患者为中心教育的定性研究 https://news.medxy.ai/ja/patient-experience/Medxy AIja2026-08-23T09:21:27-07:00肺機能検査における患者体験と理解を高める：患者中心教育に関する質的研究 https://news.medxy.ai/vi/improving-patient-experience/Medxy AIvi2026-08-23T09:21:10-07:00Nâng cao trải nghiệm và mức độ hiểu biết của người bệnh trong xét nghiệm chức năng hô hấp: Nghiên cứu định tính về giáo dục lấy người bệnh làm trung tâm https://news.medxy.ai/zh/primary-hyperparathyroidism-imaging/Medxy AIzh2026-08-23T09:19:54-07:00原发性甲状旁腺功能亢进症影像学：在疗效与安全之间寻求平衡 https://news.medxy.ai/ja/66497-2/Medxy AIja2026-08-23T09:19:35-07:00 https://news.medxy.ai/vi/balanced-safe-imaging/Medxy AIvi2026-08-23T09:19:14-07:00Cân bằng hiệu quả và an toàn: Chiến lược chẩn đoán hình ảnh có chủ đích trong cường cận giáp nguyên phát https://news.medxy.ai/zh/tert-promoter-mutations-age/Medxy AIzh2026-08-23T09:15:57-07:00TERT 启动子变异与年龄：提升乳头状甲状腺癌预后评估的精准度 https://news.medxy.ai/ja/tert-mutation-age-prognosis/Medxy AIja2026-08-23T09:15:43-07:00甲状腺乳頭癌の予後精度を高めるTERTプロモーター変異と年齢の新知見 https://news.medxy.ai/vi/tert-promoter-mutation-age/Medxy AIvi2026-08-23T09:15:23-07:00Đột biến vùng promoter của TERT và tuổi: Nâng cao độ chính xác tiên lượng trong ung thư biểu mô tuyến giáp thể nhú https://news.medxy.ai/zh/66486-2/Medxy AIzh2026-08-23T09:13:46-07:00 https://news.medxy.ai/ja/66485-2/Medxy AIja2026-08-23T09:13:28-07:00 https://news.medxy.ai/vi/hal-spectacles-myopia/Medxy AIvi2026-08-23T09:13:08-07:00Kính gọng HAL trong kiểm soát cận thị: Tổng quan toàn diện về các thử nghiệm lâm sàng gần đây và bằng chứng mới nổi https://news.medxy.ai/zh/mepolizumab-dupilumab-copd/Medxy AIzh2026-08-23T09:11:01-07:00嗜酸粒细胞性 COPD 中 mepolizumab 与 dupilumab 的疗效比较：基于匹配调整间接比较的研究启示 https://news.medxy.ai/ja/eosinophilic-copd-treatment/Medxy AIja2026-08-23T09:10:45-07:00好酸球性COPDにおけるmepolizumabとdupilumabの比較有効性：MAIC解析から見えたこと https://news.medxy.ai/vi/mepolizumab-dupilumab-copd/Medxy AIvi2026-08-23T09:10:27-07:00Mepolizumab và dupilumab trong COPD tăng bạch cầu ái toan: so sánh hiệu quả trực tiếp gián tiếp cho thấy gì? https://news.medxy.ai/zh/surgical-decisions-dementia/Medxy AIzh2026-08-23T09:08:58-07:00痴呆患者外科决策如何推进：临床挑战与实践启示 https://news.medxy.ai/ja/dementia-surgery-decisions/Medxy AIja2026-08-23T09:08:41-07:00認知症患者の手術意思決定をどう進めるか：臨床上の課題と示唆 https://news.medxy.ai/vi/surgery-decision-dementia/Medxy AIvi2026-08-23T09:08:24-07:00Ra quyết định phẫu thuật ở người bệnh sa sút trí tuệ: Những thách thức và nhận định lâm sàng https://news.medxy.ai/zh/ugh-syndrome-guide/Medxy AIzh2026-08-23T09:06:44-07:00认识现代人工晶状体相关葡萄膜炎-青光眼-前房积血（UGH）综合征：临床要点与管理 https://news.medxy.ai/ja/ugh-syndrome-guide/Medxy AIja2026-08-23T09:06:29-07:00現代の眼内レンズ関連UGH症候群を読み解く：臨床所見と治療戦略 https://news.medxy.ai/vi/ugh-syndrome-management/Medxy AIvi2026-08-23T09:06:13-07:00Hiểu đúng về hội chứng viêm màng bồ đào – tăng nhãn áp – xuất huyết tiền phòng (UGH) liên quan đến thủy tinh thể nhân tạo: Góc nhìn lâm sàng và xử trí https://news.medxy.ai/zh/66466-2/Medxy AIzh2026-08-23T09:04:41-07:00 https://news.medxy.ai/ja/airflow-limitations-copd/Medxy AIja2026-08-23T09:04:26-07:00AIRFLOW-3試験の限界：COPDに対する標的肺神経切除を再考する https://news.medxy.ai/vi/airflow3-limitations/Medxy AIvi2026-08-23T09:04:07-07:00Những hạn chế của thử nghiệm AIRFLOW-3: Giảm thần kinh phổi có mục tiêu trong COPD https://news.medxy.ai/zh/pneumonia-inflammation/Medxy AIzh2026-08-23T09:01:58-07:00重症肺炎中的炎症表型：连接临床洞见与小鼠模型，推动靶向治疗 https://news.medxy.ai/ja/severe-pneumonia-inflammation/Medxy AIja2026-08-23T09:01:42-07:00重症肺炎の炎症表現型――臨床知見とマウスモデルをつなぐ精密治療への展開 https://news.medxy.ai/vi/pneumonia-inflammation/Medxy AIvi2026-08-23T09:01:22-07:00Kiểu hình viêm trong viêm phổi nặng: Kết nối thực hành lâm sàng với mô hình chuột để phát triển điều trị nhắm đích https://news.medxy.ai/zh/bridging-gap-global-surgery/Medxy AIzh2026-08-23T08:59:34-07:00弥合鸿沟：评估澳大利亚和新西兰医学生全球外科教育现状 https://news.medxy.ai/ja/global-surgery-education/Medxy AIja2026-08-23T08:59:15-07:00世界と地域のはざまを埋める：オーストラリア・ニュージーランドの医学生におけるグローバル外科教育の評価 https://news.medxy.ai/vi/surgical-education-gap/Medxy AIvi2026-08-23T08:58:57-07:00Thu hẹp khoảng trống: Đánh giá giáo dục Ngoại khoa toàn cầu ở sinh viên y khoa tại Australia và New Zealand https://news.medxy.ai/zh/textbook-outcome-quality/Medxy AIzh2026-08-23T08:57:39-07:00以Textbook outcome评估成人心脏外科医院质量：一种稳健的基准指标 https://news.medxy.ai/ja/adult-heart-surgery-quality/Medxy AIja2026-08-23T08:57:24-07:00成人心臓手術の病院間比較におけるTextbook outcome：有用な質指標としての検証 https://news.medxy.ai/vi/surgical-outcomes/Medxy AIvi2026-08-23T08:57:07-07:00Đánh giá kết cục chuẩn mực như một chỉ số chất lượng vững chắc để so sánh bệnh viện trong phẫu thuật tim người lớn https://news.medxy.ai/zh/cathepsin-g-car-t/Medxy AIzh2026-08-23T08:53:57-07:00高亲和力 cathepsin-G 特异性 CAR T 细胞工程化构建：急性髓系白血病的新型潜在治疗策略 https://news.medxy.ai/ja/cathepsin-g-car-t-2/Medxy AIja2026-08-23T08:53:41-07:00高アビディティcathepsin-G特異的CAR T細胞の創製：急性骨髄性白血病に対する有望な治療戦略 https://news.medxy.ai/vi/car-t-cell-therapy/Medxy AIvi2026-08-23T08:53:24-07:00Kỹ thuật hóa tế bào CAR T đặc hiệu cathepsin-G có độ nhạy cao: chiến lược điều trị đầy hứa hẹn cho bệnh bạch cầu tủy cấp https://news.medxy.ai/zh/histidine-rich-glycoprotein/Medxy AIzh2026-08-23T08:51:24-07:00组氨酸富集糖蛋白：血小板黏附与聚集的新型调节因子 https://news.medxy.ai/ja/histidine-rich-glycoprotein-platelet-control/Medxy AIja2026-08-23T08:51:07-07:00Histidine-rich glycoproteinによる血小板接着・凝集制御：機序の解明と臨床的意義 https://news.medxy.ai/vi/66431-2/Medxy AIvi2026-08-23T08:50:49-07:00Glycoprotein giàu histidine điều hòa sự kết dính và ngưng tập tiểu cầu thông qua việc gắn vào GPIbα và GPIIb/IIIa. https://news.medxy.ai/ja/66428-2/Medxy AIja2026-08-23T08:48:36-07:00糖尿病網膜症の発症における遺伝要因と生活習慣の相乗作用 https://news.medxy.ai/vi/diabetic-retinopathy/Medxy AIvi2026-08-23T08:48:16-07:00Bệnh võng mạc do đái tháo đường: Sự cộng hưởng giữa gen và lối sống https://news.medxy.ai/zh/artificial-sclera-fixation/Medxy AIzh2026-08-23T08:46:42-07:00新型人工囊袋助力无缝线巩膜固定：无囊膜支持眼人工晶状体植入迎来新方案 https://news.medxy.ai/ja/new-artificial-lens-capsule/Medxy AIja2026-08-23T08:46:23-07:00被嚢支持のない眼内レンズ固定を可能にする新規人工水晶体嚢 https://news.medxy.ai/vi/scleral-fixation-bag/Medxy AIvi2026-08-23T08:46:04-07:00Túi bao giả tạo mới giúp cố định củng mạc thấu kính nội nhãn an toàn mà không cần nâng đỡ bao thể https://news.medxy.ai/navigating-surgical-decisions-in-patients-with-dementia-clinician-challenges-and-insights/Medxy AIen2026-08-22T17:16:24-07:00Navigating Surgical Decisions in Patients with Dementia: Clinician Challenges and Insights https://news.medxy.ai/beyond-survival-longitudinal-health-related-quality-of-life-after-hepatectomy-for-high-risk-colorectal-liver-metastases/Medxy AIen2026-08-22T17:14:46-07:00Beyond Survival: Longitudinal Health-related Quality of Life After Hepatectomy for High-risk Colorectal Liver Metastases https://news.medxy.ai/beyond-stenosis-how-carotid-plaque-calcification-patterns-on-cta-predict-stroke-risk/Medxy AIen2026-08-22T17:12:48-07:00Beyond Stenosis: How Carotid Plaque Calcification Patterns on CTA Predict Stroke Risk https://news.medxy.ai/trends-in-incidence-mortality-and-survival-of-endometrial-ovarian-and-cervical-cancers-in-young-nordic-women-insights-from-40-years-of-registry-data/Medxy AIen2026-08-22T17:10:45-07:00Trends in Incidence, Mortality, and Survival of Endometrial, Ovarian, and Cervical Cancers in Young Nordic Women: Insights from 40 Years of Registry Data https://news.medxy.ai/early-phase-vs-late-phase-clinical-trials-in-gynecologic-oncology-trends-in-trial-completion-reporting-and-enrollment-of-racial-and-ethnic-minority-groups/Medxy AIen2026-08-22T17:08:35-07:00Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups https://news.medxy.ai/persistent-high-risk-hpv-infection-without-major-cytological-abnormalities-clinical-insights-on-colposcopic-and-histological-outcomes/Medxy AIen2026-08-22T17:06:44-07:00Persistent High-Risk HPV Infection Without Major Cytological Abnormalities: Clinical Insights on Colposcopic and Histological Outcomes https://news.medxy.ai/minimizing-myometrial-cell-spillage-in-minimally-invasive-hysterectomy-evaluating-the-role-of-contained-manual-morcellation/Medxy AIen2026-08-22T17:04:28-07:00Minimizing Myometrial Cell Spillage in Minimally Invasive Hysterectomy: Evaluating the Role of Contained Manual Morcellation https://news.medxy.ai/gut-microbiota-and-metabolomic-signatures-as-predictors-of-immunotherapy-outcomes-in-masld-and-viral-hcc/Medxy AIen2026-08-22T17:02:00-07:00Gut Microbiota and Metabolomic Signatures as Predictors of Immunotherapy Outcomes in MASLD and Viral HCC https://news.medxy.ai/metabolic-checkpoint-role-of-pck1-deficiency-in-promoting-mash-hcc-via-12-hete-induced-cd8-t-cell-dysfunction/Medxy AIen2026-08-22T16:59:40-07:00Metabolic Checkpoint Role of PCK1 Deficiency in Promoting MASH-HCC via 12-HETE-Induced CD8+ T Cell Dysfunction https://news.medxy.ai/kif13b-kpna2-ppar-alpha-axis/Medxy AIen2026-08-22T16:57:26-07:00KIF13B-KPNA2-PPARα Axis: A Novel Target for Mitigating Alcohol-Associated Liver Steatosis https://news.medxy.ai/baseline-ischemic-burden-influences-tenecteplase-benefit-before-thrombectomy-in-acute-stroke-insights-from-the-bridge-tnk-trial/Medxy AIen2026-08-22T16:55:01-07:00Baseline Ischemic Burden Influences Tenecteplase Benefit Before Thrombectomy in Acute Stroke: Insights from the BRIDGE-TNK Trial https://news.medxy.ai/paramagnetic-rim-lesions-as-predictors-of-progression-in-multiple-sclerosis-insights-from-a-5-year-longitudinal-study/Medxy AIen2026-08-22T16:51:57-07:00Paramagnetic Rim Lesions as Predictors of Progression in Multiple Sclerosis: Insights from a 5-Year Longitudinal Study https://news.medxy.ai/optimizing-fertility-and-pregnancy-outcomes-in-women-with-congenital-adrenal-hyperplasia/Medxy AIen2026-08-22T16:49:37-07:00Optimizing Fertility and Pregnancy Outcomes in Women with Congenital Adrenal Hyperplasia https://news.medxy.ai/octreotide-in-the-management-of-catecholamine-secreting-pheochromocytomas-and-paragangliomas-a-promising-adjunctive-therapy/Medxy AIen2026-08-22T16:47:22-07:00Octreotide in the Management of Catecholamine-Secreting Pheochromocytomas and Paragangliomas: A Promising Adjunctive Therapy https://news.medxy.ai/gestational-diabetes-mellitus-ethnic-variations-in-recurrence-and-long-term-type-2-diabetes-risk/Medxy AIen2026-08-22T16:45:02-07:00Gestational Diabetes Mellitus: Ethnic Variations in Recurrence and Long-Term Type 2 Diabetes Risk https://news.medxy.ai/beta-cell-function-durability/Medxy AIen2026-08-22T16:43:00-07:00Durability of β-Cell Function After Cessation of Baricitinib Immunotherapy in New-Onset Type 1 Diabetes https://news.medxy.ai/mazdutide-a-novel-dual-agonist-demonstrates-significant-weight-loss-in-adults-with-obesity-or-overweight/Medxy AIen2026-08-22T16:40:40-07:00Mazdutide: A Novel Dual Agonist Demonstrates Significant Weight Loss in Adults with Obesity or Overweight https://news.medxy.ai/advancements-in-heart-failure-management-insights-from-the-jroadhf-and-jroadhf-next-registries/Medxy AIen2026-08-22T16:38:28-07:00Advancements in Heart Failure Management: Insights from the JROADHF and JROADHF-NEXT Registries https://news.medxy.ai/endometriosis-linked-to-elevated-long-term-risk-of-venous-thromboembolism-insights-from-a-nationwide-danish-cohort-study/Medxy AIen2026-08-22T16:36:30-07:00Endometriosis Linked to Elevated Long-Term Risk of Venous Thromboembolism: Insights from a Nationwide Danish Cohort Study https://news.medxy.ai/unveiling-the-role-of-myeloid-cells-in-right-ventricular-dysfunction-in-hfpef-via-sterile-inflammation/Medxy AIen2026-08-22T16:34:19-07:00Unveiling the Role of Myeloid Cells in Right Ventricular Dysfunction in HFpEF via Sterile Inflammation https://news.medxy.ai/bempedoic-acid-significantly-reduces-limb-and-cardiovascular-events-in-statin-intolerant-patients-with-peripheral-artery-disease-insights-from-the-clear-outcomes-trial/Medxy AIen2026-08-22T16:31:27-07:00Bempedoic Acid Significantly Reduces Limb and Cardiovascular Events in Statin-Intolerant Patients with Peripheral Artery Disease: Insights from the CLEAR Outcomes Trial https://news.medxy.ai/high-versus-low-transvaginal-cerclage-for-preventing-preterm-birth-insights-from-the-c-stich-trial-secondary-analysis/Medxy AIen2026-08-22T15:38:55-07:00High Versus Low Transvaginal Cerclage for Preventing Preterm Birth: Insights from the C-STICH Trial Secondary Analysis https://news.medxy.ai/zh/surgical-decisions-dementia/Medxy AIzh2026-08-22T10:17:23-07:00痴呆患者的外科决策：临床医生面临的挑战与洞见 https://news.medxy.ai/ja/dementia-surgery-decisions/Medxy AIja2026-08-22T10:17:06-07:00認知症患者の手術判断をどう支えるか：臨床現場の課題と示唆 https://news.medxy.ai/vi/surgery-decision-dementia/Medxy AIvi2026-08-22T10:16:43-07:00Ra quyết định phẫu thuật ở bệnh nhân sa sút trí tuệ: Thách thức và nhận định từ bác sĩ lâm sàng https://news.medxy.ai/zh/beyond-survival/Medxy AIzh2026-08-22T10:15:38-07:00超越生存：高风险结直肠癌肝转移肝切除术后健康相关生活质量的纵向研究 https://news.medxy.ai/ja/hepatic-resection-quality-of-life/Medxy AIja2026-08-22T10:15:20-07:00高リスク結腸直腸癌肝転移に対する肝切除後の健康関連QOL：生存を超えた縦断的検討 https://news.medxy.ai/vi/quality-of-life-liver-surgery/Medxy AIvi2026-08-22T10:15:02-07:00Vượt Qua Sống Còn: Chất lượng cuộc sống liên quan đến sức khỏe theo dõi dọc sau phẫu thuật cắt gan ở di căn gan do ung thư đại trực tràng nguy cơ cao https://news.medxy.ai/zh/cta-carotid-plaque/Medxy AIzh2026-08-22T10:13:49-07:00超越狭窄：CTA 识别颈动脉斑块钙化模式，如何预测卒中风险 https://news.medxy.ai/ja/carotid-plaque-calcification/Medxy AIja2026-08-22T10:13:30-07:00狭窄だけではない：CTAでみる頸動脈プラーク石灰化パターンが示す脳卒中リスク https://news.medxy.ai/vi/carotid-plaque-calcification-2/Medxy AIvi2026-08-22T10:13:08-07:00Vượt qua mức độ hẹp: Kiểu vôi hóa mảng xơ vữa động mạch cảnh trên CTA dự đoán nguy cơ đột quỵ như thế nào https://news.medxy.ai/zh/nordic-female-cancer-trends/Medxy AIzh2026-08-22T10:11:54-07:00北欧年轻女性子宫内膜癌、卵巢癌与宫颈癌发病、死亡及生存趋势：40年登记数据揭示的启示 https://news.medxy.ai/ja/nordic-gynecologic-cancer-trends/Medxy AIja2026-08-22T10:11:30-07:00ノルディック若年女性における子宮内膜癌・卵巣癌・子宮頸癌の罹患率、死亡率、生存率の推移――登録データ40年解析からの示唆 https://news.medxy.ai/vi/cancer-trends-nordic-women/Medxy AIvi2026-08-22T10:11:08-07:00Xu hướng tỷ lệ mắc, tử vong và sống còn của ung thư nội mạc tử cung, buồng trứng và cổ tử cung ở phụ nữ trẻ Bắc Âu: Góc nhìn từ dữ liệu đăng ký 40 năm https://news.medxy.ai/zh/gynecology-tumor-trials/Medxy AIzh2026-08-22T10:09:31-07:00妇科肿瘤学早期与晚期临床试验：试验完成、报告及种族/族裔少数群体入组趋势 https://news.medxy.ai/ja/gynecologic-tumor-trials/Medxy AIja2026-08-22T10:09:15-07:00婦人科腫瘍学における初期相試験と後期相試験の比較：試験完了・報告・人種的少数者登録の動向 https://news.medxy.ai/vi/gynecologic-cancer-stages/Medxy AIvi2026-08-22T10:08:53-07:00Thử nghiệm ung thư phụ khoa giai đoạn sớm và giai đoạn muộn: Xu hướng hoàn thành, báo cáo và tuyển chọn các nhóm thiểu số về chủng tộc và dân tộc https://news.medxy.ai/zh/hpv-infection-insights/Medxy AIzh2026-08-22T10:07:37-07:00持续性高危型 HPV 感染且无明显细胞学异常：阴道镜与组织学结局的临床启示 https://news.medxy.ai/ja/persistent-hrhpv-infection/Medxy AIja2026-08-22T10:07:21-07:00主要な細胞診異常がなくても見逃せない――持続的高リスクHPV感染とコルポスコピー・組織診の示唆 https://news.medxy.ai/vi/persistent-hrhpv-clinical-insights/Medxy AIvi2026-08-22T10:07:01-07:00Nhiễm hrHPV kéo dài dù tế bào học ít bất thường: Góc nhìn lâm sàng về kết quả soi cổ tử cung và mô học https://news.medxy.ai/zh/minimally-invasive-hysterectomy/Medxy AIzh2026-08-22T10:05:30-07:00微创子宫切除术中如何尽量减少子宫肌层细胞外溢：封闭式手工碎解术的作用评估 https://news.medxy.ai/ja/muscle-cell-leakage-control/Medxy AIja2026-08-22T10:05:11-07:00低侵襲子宮摘出術における筋層細胞漏出をいかに抑えるか：封じ込め下手動モルセレーションの意義を検証する https://news.medxy.ai/vi/morcellation-minimizing-leakage/Medxy AIvi2026-08-22T10:04:48-07:00Giảm thiểu rò rỉ tế bào cơ tử cung trong cắt tử cung xâm lấn tối thiểu: Vai trò của morcellation thủ công có bao chứa https://news.medxy.ai/zh/gut-microbiome-masld/Medxy AIzh2026-08-22T10:03:04-07:00肠道微生物群与代谢组学特征：预测 MASLD 与病毒性肝癌免疫治疗结局的新线索 https://news.medxy.ai/ja/masld-hcc-immunotherapy/Medxy AIja2026-08-22T10:02:44-07:00MASLDおよびウイルス性HCCにおける免疫療法予後予測因子としての腸内細菌叢とメタボロームシグネチャー https://news.medxy.ai/vi/gut-microbiota-metabolic-markers/Medxy AIvi2026-08-22T10:02:20-07:00Hệ vi sinh vật đường ruột và dấu ấn chuyển hóa: chỉ báo dự báo kết quả miễn dịch trị liệu ở HCC liên quan MASLD và viêm gan siêu vi https://news.medxy.ai/zh/pck1-deficiency-metabolic-checkpoint/Medxy AIzh2026-08-22T10:00:53-07:00PCK1缺乏通过12-HETE诱导CD8+ T细胞功能障碍促进MASH-HCC进展的代谢检查点作用 https://news.medxy.ai/ja/pck1-metabolic-checkpoint/Medxy AIja2026-08-22T10:00:34-07:0012-HETEによるCD8+ T細胞機能障害を介したMASH-HCC進展におけるPCK1欠損の代謝チェックポイントとしての役割 https://news.medxy.ai/vi/pck1-metabolic-control/Medxy AIvi2026-08-22T10:00:03-07:00Vai trò của thiếu hụt PCK1 như một điểm kiểm soát chuyển hóa trong thúc đẩy MASH-HCC qua rối loạn chức năng tế bào T CD8+ do 12-HETE https://news.medxy.ai/zh/kif13b-kpna2-ppara-axis/Medxy AIzh2026-08-22T09:58:32-07:00KIF13B-KPNA2-PPARα 轴：减轻酒精相关性肝脂肪变性的新靶点 https://news.medxy.ai/ja/kif13b-kpna2-pparalpha-axis/Medxy AIja2026-08-22T09:58:09-07:00KIF13B-KPNA2-PPARα軸：アルコール関連肝脂肪化を抑える新規標的 https://news.medxy.ai/vi/kif13b-kpna2-ppara-target/Medxy AIvi2026-08-22T09:57:48-07:00Trục KIF13B-KPNA2-PPARα: Mục tiêu mới tiềm năng để giảm gan nhiễm mỡ liên quan đến rượu https://news.medxy.ai/zh/stroke-ischemia-benefit/Medxy AIzh2026-08-22T09:55:54-07:00急性卒中中基线缺血负荷影响取栓前替奈普酶获益：来自 BRIDGE-TNK 试验的洞见 https://news.medxy.ai/ja/tnk-efficacy-stroke/Medxy AIja2026-08-22T09:55:35-07:00急性脳卒中における血栓回収療法前テネクテプラーゼの有効性はベースライン虚血負荷で変わる：BRIDGE-TNK試験からの知見 https://news.medxy.ai/vi/ischemia-level-tenecteplase/Medxy AIvi2026-08-22T09:55:18-07:00Mức độ thiếu máu cục bộ nền chi phối lợi ích của tenecteplase trước lấy huyết khối trong đột quỵ cấp: Góc nhìn từ thử nghiệm BRIDGE-TNK https://news.medxy.ai/zh/paramagnetic-lesions-ms-progress/Medxy AIzh2026-08-22T09:52:59-07:00顺磁性边缘病灶可预测多发性硬化进展：一项 5 年纵向研究的启示 https://news.medxy.ai/ja/ms-progression-predictors/Medxy AIja2026-08-22T09:52:38-07:00多発性硬化症における進行予測因子としての常磁性リム病変：5年間縦断研究からの知見 https://news.medxy.ai/vi/magnetic-lesions-ms/Medxy AIvi2026-08-22T09:52:17-07:00Lesion vành từ tính có dự báo tiến triển trong bệnh đa xơ cứng không? Bằng chứng từ nghiên cứu theo dõi 5 năm https://news.medxy.ai/zh/congenital-adrenal-hyperplasia-pregnancy/Medxy AIzh2026-08-22T09:50:39-07:00先天性肾上腺皮质增生症女性的生育与妊娠结局优化 https://news.medxy.ai/ja/congenital-adrenal-hyperplasia/Medxy AIja2026-08-22T09:50:20-07:00先天性副腎過形成女性における妊孕性と妊娠転帰の最適化 https://news.medxy.ai/vi/fertility-pregnancy-optimization/Medxy AIvi2026-08-22T09:49:57-07:00Tối ưu hóa khả năng sinh sản và kết cục thai kỳ ở phụ nữ mắc tăng sản thượng thận bẩm sinh https://news.medxy.ai/zh/octreotide-role/Medxy AIzh2026-08-22T09:48:17-07:00奥曲肽在分泌儿茶酚胺的嗜铬细胞瘤与副神经节瘤管理中的作用：一种有前景的辅助治疗 https://news.medxy.ai/ja/octreotide-role-2/Medxy AIja2026-08-22T09:48:00-07:00カテコールアミン分泌性褐色細胞腫・傍神経節腫におけるOctreotideの役割：有望な補助療法 https://news.medxy.ai/vi/octreotide-pheochromocytoma-treatment/Medxy AIvi2026-08-22T09:47:40-07:00Octreotide trong điều trị pheochromocytoma và paraganglioma tiết catecholamine: một liệu pháp bổ trợ đầy hứa hẹn https://news.medxy.ai/zh/gestational-diabetes-risks-3/Medxy AIzh2026-08-22T09:45:54-07:00妊娠期糖尿病：复发及长期2型糖尿病风险的族裔差异 https://news.medxy.ai/ja/66197-2/Medxy AIja2026-08-22T09:45:37-07:00妊娠糖尿病：人種・民族集団間における再発および将来の2型糖尿病リスク https://news.medxy.ai/vi/gestational-diabetes-risk-2/Medxy AIvi2026-08-22T09:45:20-07:00Đái tháo đường thai kỳ: Khác biệt theo sắc tộc trong nguy cơ tái phát và nguy cơ đái tháo đường type 2 lâu dài https://news.medxy.ai/zh/bari-therapy-duration/Medxy AIzh2026-08-22T09:43:54-07:00巴瑞替尼停药后新发1型糖尿病β细胞功能可维持多久？ https://news.medxy.ai/ja/beta-cell-function-persistence/Medxy AIja2026-08-22T09:43:37-07:00新規発症1型糖尿病におけるbaricitinib中止後のβ細胞機能の持続性 https://news.medxy.ai/vi/baricitinib-treatment-discontinuation/Medxy AIvi2026-08-22T09:43:19-07:00Baricitinib ngừng điều trị: Chức năng tế bào β còn được duy trì bao lâu ở đái tháo đường typ 1 khởi phát mới? https://news.medxy.ai/zh/mazdutide-weight-loss/Medxy AIzh2026-08-22T09:41:40-07:00Mazdutide：新型双重激动剂在肥胖与超重成人中显示显著减重效果 https://news.medxy.ai/ja/mazdutide-weight-loss-3/Medxy AIja2026-08-22T09:41:18-07:00Mazdutide：新規二重作動薬が肥満・過体重の成人で有意な体重減少を示す https://news.medxy.ai/vi/mazdutide-weight-loss-2/Medxy AIvi2026-08-22T09:40:58-07:00Mazdutide: Chất chủ vận kép mới cho thấy hiệu quả giảm cân đáng kể ở người lớn mắc béo phì hoặc thừa cân https://news.medxy.ai/zh/heart-failure-management/Medxy AIzh2026-08-22T09:39:18-07:00日本心力衰竭管理的进展：来自 JROADHF 与 JROADHF-NEXT 登记研究的启示 https://news.medxy.ai/ja/heart-failure-advances/Medxy AIja2026-08-22T09:39:02-07:00心不全診療はどう進歩したか――JROADHF／JROADHF-NEXTレジストリが示す日本の変化 https://news.medxy.ai/vi/heart-failure-management-advances/Medxy AIvi2026-08-22T09:38:44-07:00Những tiến bộ trong quản lý suy tim: Góc nhìn từ các cơ sở dữ liệu đăng ký JROADHF và JROADHF-NEXT https://news.medxy.ai/zh/endometriosis-thrombosis-risk/Medxy AIzh2026-08-22T09:37:32-07:00子宫内膜异位症与静脉血栓栓塞长期风险升高相关：来自丹麦全国队列研究的启示 https://news.medxy.ai/ja/endometriosis-thrombosis-risk-2/Medxy AIja2026-08-22T09:37:15-07:00子宮内膜症は静脈血栓塞栓症の長期リスク上昇と関連：デンマーク全国コホート研究からの知見 https://news.medxy.ai/vi/endometriosis-blood-clots/Medxy AIvi2026-08-22T09:36:51-07:00Lạc nội mạc tử cung liên quan đến nguy cơ huyết khối tĩnh mạch thuyên tắc dài hạn tăng cao: Góc nhìn từ nghiên cứu đoàn hệ toàn quốc tại Đan Mạch https://news.medxy.ai/zh/myeloid-cells-hfpef/Medxy AIzh2026-08-22T09:35:15-07:00揭示无菌性炎症在 HFpEF 右心室功能障碍中的髓系细胞作用 https://news.medxy.ai/ja/right-ventricle-hfpef/Medxy AIja2026-08-22T09:34:58-07:00無菌性炎症が明かすHFpEFにおける右室機能障害と骨髄系細胞の役割 https://news.medxy.ai/vi/myeloid-cells-hfpef-2/Medxy AIvi2026-08-22T09:34:38-07:00Vai trò của tế bào myeloid trong rối loạn chức năng thất phải ở HFpEF: bằng chứng từ viêm vô khuẩn https://news.medxy.ai/zh/bempedoic-acid-results/Medxy AIzh2026-08-22T09:32:30-07:00Bempedoic acid在他汀不耐受的外周动脉疾病患者中显著减少肢体和心血管事件：来自CLEAR Outcomes试验的启示 https://news.medxy.ai/ja/66135-2/Medxy AIja2026-08-22T09:32:12-07:00末梢動脈疾患を有しスタチン不耐容の患者におけるベムペド酸と初回および再発の四肢関連転帰：CLEAR Outcomes試験からの知見 https://news.medxy.ai/vi/bempedoic-acid-benefits/Medxy AIvi2026-08-22T09:31:48-07:00Axit bempedoic làm giảm rõ rệt biến cố chi và tim mạch ở bệnh nhân bệnh động mạch ngoại biên không dung nạp statin: Góc nhìn từ thử nghiệm CLEAR Outcomes https://news.medxy.ai/zh/cervical-cerclage-prevention/Medxy AIzh2026-08-22T08:39:55-07:00高位还是低位经阴道宫颈环扎术更能预防早产？C-STICH试验二次分析揭示新线索 https://news.medxy.ai/ja/66123-2/Medxy AIja2026-08-22T08:39:36-07:00早産予防における高位対低位経腟頸管縫縮術：C-STICH試験の二次解析からの知見 https://news.medxy.ai/vi/66122-2/Medxy AIvi2026-08-22T08:39:14-07:00So sánh kỹ thuật khâu vòng cổ tử cung qua đường âm đạo ở vị trí cao và thấp nhằm ngăn ngừa sinh non: Những hiểu biết từ phân tích thứ cấp của thử nghiệm C-STICH https://news.medxy.ai/divergent-roles-of-federal-and-industry-sponsors-in-us-cancer-clinical-trials-insights-from-2008-to-2024/Medxy AIen2026-08-22T08:37:39-07:00Divergent Roles of Federal and Industry Sponsors in US Cancer Clinical Trials: Insights from 2008 to 2024 https://news.medxy.ai/decoding-systemic-inflammation-in-long-covid-and-autoimmune-diseases-the-role-of-intestinal-flagellin-and-the-tlr5-il-15-ara-axis/Medxy AIen2026-08-22T08:37:26-07:00Decoding Systemic Inflammation in Long COVID and Autoimmune Diseases: The Role of Intestinal Flagellin and the TLR5-IL-15-ARA Axis https://news.medxy.ai/zh/federal-vs-industry-funding-2/Medxy AIzh2026-08-22T08:15:58-07:00联邦与行业资助在美国癌症临床试验中的分工差异：2008—2024 年研究洞见 https://news.medxy.ai/ja/us-cancer-trial-sponsors/Medxy AIja2026-08-22T08:15:41-07:00米国がん臨床試験における連邦スポンサーと産業スポンサーの異なる役割：2008年から2024年の知見 https://news.medxy.ai/vi/federal-vs-industry-cancer-trials/Medxy AIvi2026-08-22T08:15:13-07:00Vai trò khác biệt của tài trợ liên bang và công nghiệp trong các thử nghiệm lâm sàng ung thư tại Hoa Kỳ: Những phát hiện từ giai đoạn 2008–2024 https://news.medxy.ai/zh/long-covid-inflammation/Medxy AIzh2026-08-22T08:13:26-07:00解析长新冠与自身免疫病中的全身炎症：肠道鞭毛蛋白及TLR5-IL-15-ARA轴的关键作用 https://news.medxy.ai/ja/long-covid-autoimmune-inflammation/Medxy AIja2026-08-22T08:13:07-07:00long COVIDと自己免疫疾患における全身性炎症の解読：腸内フラジェリンとTLR5-IL-15-ARA軸の役割 https://news.medxy.ai/vi/long-covid-autoimmune/Medxy AIvi2026-08-22T08:12:43-07:00Giải mã viêm hệ thống trong long COVID và các bệnh tự miễn: vai trò của flagellin đường ruột và trục TLR5-IL-15-ARA https://news.medxy.ai/impact-of-palate-repair-timing-within-first-15-months-on-early-speech-development-in-children-with-cleft-palate/Medxy AIen2026-08-21T11:28:05-07:00Impact of Palate Repair Timing within First 15 Months on Early Speech Development in Children with Cleft Palate https://news.medxy.ai/pembrolizumab-plus-quad-shot-radiotherapy-a-promising-approach-for-recurrent-unresectable-head-and-neck-cancer/Medxy AIen2026-08-21T11:27:54-07:00Pembrolizumab Plus Quad-Shot Radiotherapy: A Promising Approach for Recurrent, Unresectable Head and Neck Cancer https://news.medxy.ai/enhancing-vestibular-migraine-rehabilitation-with-virtual-reality-a-randomized-controlled-trial/Medxy AIen2026-08-21T11:27:40-07:00Enhancing Vestibular Migraine Rehabilitation with Virtual Reality: A Randomized Controlled Trial https://news.medxy.ai/expanding-pediatric-cochlear-implant-indications-multicenter-evidence-supports-safety-and-efficacy-in-younger-children-and-those-with-residual-hearing/Medxy AIen2026-08-21T11:27:24-07:00Expanding Pediatric Cochlear Implant Indications: Multicenter Evidence Supports Safety and Efficacy in Younger Children and Those with Residual Hearing https://news.medxy.ai/impact-of-trauma-on-social-risk-insights-from-serial-hospital-data-screening/Medxy AIen2026-08-21T11:27:11-07:00Impact of Trauma on Social Risk: Insights from Serial Hospital Data Screening https://news.medxy.ai/early-uptake-of-broad-spectrum-antibiotic-prophylaxis-in-pancreatoduodenectomy-translating-trial-evidence-into-practice/Medxy AIen2026-08-21T11:26:58-07:00Early Uptake of Broad-Spectrum Antibiotic Prophylaxis in Pancreatoduodenectomy: Translating Trial Evidence into Practice https://news.medxy.ai/evaluating-preoperative-high-dose-corticosteroids-in-digestive-cancer-surgery-insights-from-a-large-multicenter-randomized-trial/Medxy AIen2026-08-21T11:26:44-07:00Evaluating Preoperative High-Dose Corticosteroids in Digestive Cancer Surgery: Insights from a Large Multicenter Randomized Trial https://news.medxy.ai/new-2026-multisociety-guidelines-for-atypical-breast-lesions-and-lcis-what-clinicians-need-to-know/Medxy AIen2026-08-21T11:26:30-07:00New 2026 Multisociety Guidelines for Atypical Breast Lesions and LCIS: What Clinicians Need to Know https://news.medxy.ai/navigating-intraoperative-challenges-in-robot-assisted-minimally-invasive-esophagectomy-incidence-management-and-surgical-outcomes/Medxy AIen2026-08-21T11:26:15-07:00Navigating Intraoperative Challenges in Robot-assisted Minimally Invasive Esophagectomy: Incidence, Management, and Surgical Outcomes https://news.medxy.ai/patterns-and-implications-of-local-regrowth-after-neoadjuvant-chemoradiotherapy-in-esophageal-cancer-insights-from-the-sano-trial/Medxy AIen2026-08-21T11:25:59-07:00Patterns and Implications of Local Regrowth After Neoadjuvant Chemoradiotherapy in Esophageal Cancer: Insights from the SANO Trial https://news.medxy.ai/enhancing-patient-engagement-in-gynecologic-oncology-clinical-trials-through-a-pilot-patient-ambassador-program/Medxy AIen2026-08-21T11:25:45-07:00Enhancing Patient Engagement in Gynecologic Oncology Clinical Trials Through a Pilot Patient Ambassador Program https://news.medxy.ai/niraparib-versus-platinum-taxane-chemotherapy-as-neoadjuvant-treatment-in-advanced-hr-deficient-ovarian-cancer-insights-from-the-opal-phase-2-trial/Medxy AIen2026-08-21T11:25:29-07:00Niraparib Versus Platinum-Taxane Chemotherapy as Neoadjuvant Treatment in Advanced HR-Deficient Ovarian Cancer: Insights from the OPAL Phase 2 Trial https://news.medxy.ai/bridging-perspectives-patient-and-clinician-views-on-postpartum-venous-thromboembolism-risk-and-thromboprophylaxis-use/Medxy AIen2026-08-21T11:25:15-07:00Bridging Perspectives: Patient and Clinician Views on Postpartum Venous Thromboembolism Risk and Thromboprophylaxis Use https://news.medxy.ai/high-versus-low-vaginal-cerclage-effects-on-pregnancy-outcomes-in-women-at-high-risk-of-preterm-birth/Medxy AIen2026-08-21T11:25:00-07:00High Versus Low Vaginal Cerclage: Effects on Pregnancy Outcomes in Women at High Risk of Preterm Birth https://news.medxy.ai/minimally-invasive-prediction-models-for-intra-amniotic-infection-and-early-delivery-risk-in-preterm-labor/Medxy AIen2026-08-21T11:24:44-07:00Minimally Invasive Prediction Models for Intra-Amniotic Infection and Early Delivery Risk in Preterm Labor https://news.medxy.ai/gynecologic-cancer-disparities/Medxy AIen2026-08-21T11:24:20-07:00Disparities in Gynecologic Cancer Diagnosis in the U.S. (2001–2019): The Roles of Race, Social Vulnerability, and Specialist Access https://news.medxy.ai/innovative-single-port-transabdominal-hysteroscopic-technique-for-perforated-iud-removal/Medxy AIen2026-08-21T11:24:05-07:00Innovative Single-Port Transabdominal Hysteroscopic Technique for Perforated IUD Removal https://news.medxy.ai/recurrent-severe-hypertensive-disorders-in-pregnancy-evaluating-risks-and-outcomes-for-future-pregnancies/Medxy AIen2026-08-21T11:23:51-07:00Recurrent Severe Hypertensive Disorders in Pregnancy: Evaluating Risks and Outcomes for Future Pregnancies https://news.medxy.ai/targeting-nek7-mediated-egfr-phosphorylation-to-overcome-lenvatinib-resistance-in-hepatocellular-carcinoma/Medxy AIen2026-08-21T11:23:39-07:00Targeting NEK7-Mediated EGFR Phosphorylation to Overcome Lenvatinib Resistance in Hepatocellular Carcinoma https://news.medxy.ai/multiomic-profiling-and-machine-learning-reveal-distinct-molecular-subtypes-of-cholangiocarcinoma-and-identify-tnk1-as-a-novel-therapeutic-target/Medxy AIen2026-08-21T11:23:28-07:00Multiomic Profiling and Machine Learning Reveal Distinct Molecular Subtypes of Cholangiocarcinoma and Identify TNK1 as a Novel Therapeutic Target https://news.medxy.ai/rethinking-meningioma-management-incidence-surge-amid-stable-treatment-and-extensive-imaging-surveillance/Medxy AIen2026-08-21T11:23:05-07:00Rethinking Meningioma Management: Incidence Surge Amid Stable Treatment and Extensive Imaging Surveillance https://news.medxy.ai/metrnl-a-novel-inhibitor-of-platelet-activation-targeting-cd36-to-mitigate-thrombosis-and-acute-myocardial-injury/Medxy AIen2026-08-21T11:22:53-07:00Metrnl: A Novel Inhibitor of Platelet Activation Targeting CD36 to Mitigate Thrombosis and Acute Myocardial Injury https://news.medxy.ai/semaglutide-inflammation-risk/Medxy AIen2026-08-21T11:22:40-07:00Semaglutide’s Impact on Inflammation and Cardiovascular Risk in Overweight Patients: Insights from the SELECT Trial https://news.medxy.ai/ai-ecg-for-detecting-structural-heart-disease-in-the-community-evaluating-real-world-applicability-in-the-prevue-valve-study/Medxy AIen2026-08-21T11:22:28-07:00AI-ECG for Detecting Structural Heart Disease in the Community: Evaluating Real-World Applicability in the PREVUE-VALVE Study https://news.medxy.ai/unmasking-silent-heart-failure-in-diabetes-insights-from-the-tartan-hf-trial/Medxy AIen2026-08-21T11:22:14-07:00Unmasking Silent Heart Failure in Diabetes: Insights from the TARTAN-HF Trial https://news.medxy.ai/unveiling-hidden-immune-signatures-in-cardiovascular-disease-through-single-cell-multi-omics/Medxy AIen2026-08-21T11:22:02-07:00Unveiling Hidden Immune Signatures in Cardiovascular Disease Through Single-Cell Multi-Omics https://news.medxy.ai/runx1-driven-endothelial-to-mesenchymal-transition-a-novel-mechanistic-link-and-therapeutic-target-in-lmna-cardiomyopathy/Medxy AIen2026-08-21T11:21:50-07:00RUNX1-Driven Endothelial-to-Mesenchymal Transition: A Novel Mechanistic Link and Therapeutic Target in LMNA Cardiomyopathy https://news.medxy.ai/left-atrial-dysfunction-and-vutrisiran-efficacy-in-transthyretin-amyloid-cardiomyopathy-insights-from-the-helios-b-trial/Medxy AIen2026-08-21T11:21:38-07:00Left Atrial Dysfunction and Vutrisiran Efficacy in Transthyretin Amyloid Cardiomyopathy: Insights from the HELIOS-B Trial https://news.medxy.ai/age-specific-excess-healthcare-burden-of-diabetes-beyond-traditional-complications/Medxy AIen2026-08-21T11:21:27-07:00Age-Specific Excess Healthcare Burden of Diabetes: Beyond Traditional Complications https://news.medxy.ai/supar-as-a-novel-marker-for-residual-inflammatory-risk-beyond-hs-crp-in-type-2-diabetes-with-coronary-artery-disease/Medxy AIen2026-08-21T11:21:08-07:00suPAR as a Novel Marker for Residual Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes with Coronary Artery Disease https://news.medxy.ai/circulating-mir-1-3p-precedes-adrenarche-and-modulates-adrenocortical-steroidogenesis-via-protein-kinase-c-signaling/Medxy AIen2026-08-21T11:20:57-07:00Circulating miR-1-3p Precedes Adrenarche and Modulates Adrenocortical Steroidogenesis via Protein Kinase C Signaling https://news.medxy.ai/dulaglutide-versus-insulin-in-adolescents-with-thalassaemia-induced-diabetes-improving-glycaemic-control-and-metabolic-health-in-a-high-risk-population/Medxy AIen2026-08-21T11:20:44-07:00Dulaglutide Versus Insulin in Adolescents With Thalassaemia-Induced Diabetes: Improving Glycaemic Control and Metabolic Health in a High-Risk Population https://news.medxy.ai/menopausal-transition-and-thyroid-function-deciphering-the-impact-beyond-aging-in-midlife-women/Medxy AIen2026-08-21T11:20:32-07:00Menopausal Transition and Thyroid Function: Deciphering the Impact Beyond Aging in Midlife Women https://news.medxy.ai/long-term-fatigue-in-differentiated-thyroid-cancer-survivors-early-predictors-and-the-non-impact-of-thyrotropin-suppression/Medxy AIen2026-08-21T11:20:19-07:00Long-Term Fatigue in Differentiated Thyroid Cancer Survivors: Early Predictors and the Non-Impact of Thyrotropin Suppression https://news.medxy.ai/delineating-the-roles-of-federal-and-industry-sponsorship-in-us-cancer-clinical-trials/Medxy AIen2026-08-21T11:20:02-07:00Delineating the Roles of Federal and Industry Sponsorship in US Cancer Clinical Trials https://news.medxy.ai/refining-treatment-monitoring-in-patients-with-relapsing-multiple-sclerosis-based-on-changes-on-neurofilament-light-chain-z-scores/Medxy AIen2026-08-21T11:19:37-07:00Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores https://news.medxy.ai/ldl-c-reduction/Medxy AIen2026-08-21T11:19:24-07:00Optimizing LDL-C Reduction Strategies in Ischemic Stroke: Impact of Achieving ≥50% LDL-C Reduction from Baseline https://news.medxy.ai/colchicine-for-secondary-prevention-after-stroke-according-to-the-presence-of-atherosclerosis-clinical-evidence-and-implications/Medxy AIen2026-08-21T11:19:10-07:00Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis: Clinical Evidence and Implications https://news.medxy.ai/unraveling-the-gut-lung-axis-intestinal-flagellin-as-a-driver-of-multisystem-inflammation-via-the-tlr5-il-15-ara-pathway/Medxy AIen2026-08-21T11:18:59-07:00Unraveling the Gut-Lung Axis: Intestinal Flagellin as a Driver of Multisystem Inflammation via the TLR5-IL-15-ARA Pathway https://news.medxy.ai/targeting-nsun6-deficiency-to-overcome-immune-suppression-in-pancreatic-cancer-insights-into-the-kdm5a-ccl2-macrophage-axis/Medxy AIen2026-08-21T11:18:47-07:00Targeting NSUN6 Deficiency to Overcome Immune Suppression in Pancreatic Cancer: Insights into the KDM5A-CCL2-Macrophage Axis https://news.medxy.ai/zh/palate-repair-timing/Medxy AIzh2026-08-21T10:54:33-07:00腭修复越早越有利？15个月内手术时机与儿童早期言语发育的关系 https://news.medxy.ai/ja/palate-repair-timing-2/Medxy AIja2026-08-21T10:54:16-07:00口蓋裂児の早期発話発達に対する、15か月未満での口蓋修復時期の影響 https://news.medxy.ai/vi/cleft-palate-repair-timing/Medxy AIvi2026-08-21T10:53:56-07:00Thời điểm sửa chữa khẩu cái trong 15 tháng đầu đời ảnh hưởng thế nào đến phát triển lời nói sớm ở trẻ hở hàm ếch https://news.medxy.ai/zh/pembrolizumab-radiotherapy/Medxy AIzh2026-08-21T10:52:49-07:00帕博利珠单抗联合四照射放疗：复发、不可切除头颈癌的潜力方案 https://news.medxy.ai/ja/head-neck-cancer-strategy/Medxy AIja2026-08-21T10:52:33-07:00再発・切除不能頭頸部癌に挑む新戦略：ペムブロリズマブ併用quad-shot放射線療法の可能性 https://news.medxy.ai/vi/pembrolizumab-radiation-therapy/Medxy AIvi2026-08-21T10:52:14-07:00Pembrolizumab phối hợp xạ trị quad-shot: hướng đi đầy triển vọng cho ung thư đầu và cổ tái phát không thể phẫu thuật https://news.medxy.ai/zh/vr-vestibular-rehabilitation/Medxy AIzh2026-08-21T10:50:50-07:00虚拟现实加持前庭康复：前庭性偏头痛随机对照试验证实症状与平衡控制获益 https://news.medxy.ai/ja/vestibular-migraine-rehabilitation/Medxy AIja2026-08-21T10:50:28-07:00仮想現実を活用した前庭リハビリテーションで前庭性片頭痛の回復を高める：ランダム化比較試験 https://news.medxy.ai/vi/migraine-vestibular-recovery/Medxy AIvi2026-08-21T10:50:06-07:00Tăng cường phục hồi migraine tiền đình bằng thực tế ảo: Kết quả từ một thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/zh/cochlear-implant-expansion/Medxy AIzh2026-08-21T10:48:47-07:00儿童人工耳蜗适应证再拓宽：多中心证据支持更小年龄及残余听力儿童的安全性与有效性 https://news.medxy.ai/ja/expanded-pediatric-cochlear-implant/Medxy AIja2026-08-21T10:48:30-07:00小児人工内耳の適応拡大へ――低年齢児と残存聴力例を支持する多施設エビデンス https://news.medxy.ai/vi/cochlear-implant-expansion-2/Medxy AIvi2026-08-21T10:48:09-07:00Mở rộng chỉ định cấy ốc tai điện tử ở trẻ em: Bằng chứng đa trung tâm ủng hộ độ an toàn và hiệu quả ở trẻ nhỏ hơn và trẻ còn thính lực tồn dư https://news.medxy.ai/zh/trauma-social-risk-impact/Medxy AIzh2026-08-21T10:44:03-07:00创伤对社会风险的影响：基于连续住院数据筛查的研究洞见 https://news.medxy.ai/ja/trauma-social-risk-impact-2/Medxy AIja2026-08-21T10:43:48-07:00外傷が社会的リスクに及ぼす影響：連続的病院スクリーニングデータからの知見 https://news.medxy.ai/vi/trauma-social-risk/Medxy AIvi2026-08-21T10:43:27-07:00Chấn thương làm gia tăng nguy cơ xã hội: Nhận định từ dữ liệu sàng lọc liên tiếp tại bệnh viện https://news.medxy.ai/zh/early-antibiotic-use-pancreaticoduodenectomy/Medxy AIzh2026-08-21T10:42:21-07:00胰十二指肠切除术广谱抗生素预防用药的早期应用：从试验证据到临床实践的转化 https://news.medxy.ai/ja/early-antibiotic-prophylaxis/Medxy AIja2026-08-21T10:41:58-07:00膵頭十二指腸切除術における広域抗菌薬予防投与の早期導入：試験エビデンスの実臨床への橋渡し https://news.medxy.ai/vi/early-broad-spectrum-antibiotics/Medxy AIvi2026-08-21T10:41:36-07:00Dự phòng kháng sinh phổ rộng được áp dụng sớm trong phẫu thuật cắt tá tụy: Từ bằng chứng thử nghiệm đến thực hành https://news.medxy.ai/zh/preoperative-steroids-cancer-surgery/Medxy AIzh2026-08-21T10:40:30-07:00消化系统癌症手术中术前大剂量糖皮质激素的价值：来自大型多中心随机试验的证据 https://news.medxy.ai/ja/preoperative-steroids-cancer/Medxy AIja2026-08-21T10:40:13-07:00消化器がん手術における術前高用量コルチコステロイド：大規模多施設無作為化試験から見えたもの https://news.medxy.ai/vi/high-dose-corticosteroids-surgery/Medxy AIvi2026-08-21T10:39:56-07:00Corticosteroids liều cao trước phẫu thuật trong phẫu thuật ung thư tiêu hóa: Góc nhìn từ một thử nghiệm ngẫu nhiên đa trung tâm quy mô lớn https://news.medxy.ai/ja/atypical-breast-lesions-lcis/Medxy AIja2026-08-21T10:38:43-07:002026年版 多学会ガイドラインで整理された異型乳腺病変とLCIS：臨床医が押さえるべき要点 https://news.medxy.ai/vi/atypical-breast-lesions-guide/Medxy AIvi2026-08-21T10:38:15-07:00Hướng dẫn đa chuyên khoa 2026 về tổn thương vú không điển hình và LCIS: Bác sĩ lâm sàng cần biết gì https://news.medxy.ai/zh/2026-breast-lesion-guidelines/Medxy AIzh2026-08-21T10:37:46-07:002026年多学会乳腺非典型病变与LCIS新指南：临床医生需要掌握的要点 https://news.medxy.ai/zh/robotic-esophagectomy-challenges/Medxy AIzh2026-08-21T10:35:56-07:00机器人辅助微创食管切除术中的术中挑战：发生率、处理与手术结局 https://news.medxy.ai/ja/robotic-esophagectomy-troubles/Medxy AIja2026-08-21T10:35:39-07:00ロボット支援低侵襲食道切除術における術中トラブルを読み解く：発生頻度、対応、手術成績 https://news.medxy.ai/vi/robotic-esophagectomy-challenges-2/Medxy AIvi2026-08-21T10:35:21-07:00Vượt qua thách thức trong mổ ở cắt thực quản xâm lấn tối thiểu có hỗ trợ robot: tỷ lệ mắc, xử trí và kết quả phẫu thuật https://news.medxy.ai/zh/esophageal-cancer-local-recurrence/Medxy AIzh2026-08-21T10:34:07-07:00食管癌新辅助放化疗后局部再生长的模式与临床意义：来自SANO试验的观察 https://news.medxy.ai/ja/esophageal-cancer-recurrence/Medxy AIja2026-08-21T10:33:46-07:00食道癌における術前化学放射線療法後の局所再増殖パターンと臨床的意義：SANO試験からの知見 https://news.medxy.ai/vi/local-recurrence-esophageal-cancer/Medxy AIvi2026-08-21T10:33:27-07:00Kiểu tái phát tại chỗ sau hóa xạ trị tân bổ trợ trong ung thư thực quản: Góc nhìn từ thử nghiệm SANO https://news.medxy.ai/zh/patient-ambassador-pilot/Medxy AIzh2026-08-21T10:32:16-07:00患者大使试点项目助力提升妇科肿瘤临床试验参与度 https://news.medxy.ai/ja/gynecologic-tumor-trial/Medxy AIja2026-08-21T10:31:58-07:00患者アンバサダー・プログラムで高める婦人科腫瘍臨床試験への参加意欲 https://news.medxy.ai/vi/65942-2/Medxy AIvi2026-08-21T10:31:37-07:00Đánh giá chương trình đại sứ bệnh nhân nhằm nâng cao kiến ​​thức về thử nghiệm lâm sàng và ý định thảo luận về các thử nghiệm ung thư phụ khoa https://news.medxy.ai/zh/opal2-niraparib-ovarian-cancer/Medxy AIzh2026-08-21T10:30:25-07:00OPAL 2 期研究解读：niraparib 作为晚期 HR 缺陷卵巢癌新辅助治疗不及铂类-紫杉烷化疗 https://news.medxy.ai/ja/65933-2/Medxy AIja2026-08-21T10:30:08-07:00新規診断された相同組換え修復欠損（HRD）を有するIII/IV期卵巣癌患者における術前化学療法としてのニラパリブとプラチナ製剤・タキサン系薬剤併用療法の比較：OPAL第II相試験コホートCの成績 https://news.medxy.ai/vi/niraparib-vs-chemotherapy/Medxy AIvi2026-08-21T10:29:50-07:00Niraparib so với hóa trị platinum-taxane trong điều trị trước phẫu thuật ung thư buồng trứng tiến triển có thiếu hụt HR: Góc nhìn từ thử nghiệm OPAL pha 2 https://news.medxy.ai/zh/postpartum-thrombosis-risk/Medxy AIzh2026-08-21T10:28:37-07:00跨越认知鸿沟：患者与临床医生对产后静脉血栓栓塞风险及血栓预防使用的看法 https://news.medxy.ai/ja/65924-2/Medxy AIja2026-08-21T10:28:22-07:00認識のギャップを埋める：産後の静脈血栓塞栓症リスクおよび血栓予防策の実施に関する患者と医療従事者の見解 https://news.medxy.ai/vi/venous-thromboembolism-awareness/Medxy AIvi2026-08-21T10:28:01-07:00Từ góc nhìn bệnh nhân đến bác sĩ: Nhận thức về nguy cơ huyết khối tĩnh mạch thuyên tắc sau sinh và việc sử dụng dự phòng https://news.medxy.ai/zh/cervical-cerclage-benefits/Medxy AIzh2026-08-21T10:24:11-07:00高位还是低位宫颈环扎更有利？对高早产风险女性妊娠结局的影响 https://news.medxy.ai/ja/transvaginal-cervical-cerclage/Medxy AIja2026-08-21T10:23:50-07:00高位と低位の経膣的頸管縫縮術：早産高リスク女性の妊娠転帰への影響 https://news.medxy.ai/vi/cervical-suture-impact/Medxy AIvi2026-08-21T10:23:28-07:00Khâu cổ tử cung âm đạo cao hay thấp: Ảnh hưởng đến kết cục thai kỳ ở phụ nữ có nguy cơ sinh non cao https://news.medxy.ai/zh/preterm-labor-infection-model/Medxy AIzh2026-08-21T10:22:10-07:00早产临产中宫内感染与早产风险的微创预测模型 https://news.medxy.ai/ja/amnion-infection-risk/Medxy AIja2026-08-21T10:21:48-07:00早産陣痛における羊膜内感染と早期分娩リスクを予測する低侵襲モデル https://news.medxy.ai/vi/infection-prediction-models/Medxy AIvi2026-08-21T10:21:26-07:00Các mô hình dự đoán ít xâm lấn về nhiễm trùng trong buồng ối và nguy cơ sinh sớm ở chuyển dạ sinh non https://news.medxy.ai/zh/us-gynecologic-cancer-disparities/Medxy AIzh2026-08-21T10:19:57-07:00美国妇科癌症诊断差异（2001—2019）：种族、社会脆弱性与专科可及性的作用 https://news.medxy.ai/ja/gynecological-cancer-disparities-us/Medxy AIja2026-08-21T10:19:33-07:00米国における婦人科がん診断の格差（2001～2019年）――人種、社会的脆弱性、専門医アクセスの影響 https://news.medxy.ai/vi/gynecologic-cancer-disparities-2/Medxy AIvi2026-08-21T10:19:09-07:00Chênh lệch trong chẩn đoán ung thư phụ khoa tại Hoa Kỳ (2001–2019): Vai trò của chủng tộc, mức độ tổn thương xã hội và khả năng tiếp cận bác sĩ chuyên khoa https://news.medxy.ai/zh/single-port-hysteroscopic-iud-removal/Medxy AIzh2026-08-21T10:17:50-07:00单孔经腹宫腔镜取出穿孔IUD：微创新技术 https://news.medxy.ai/ja/innovative-iud-removal/Medxy AIja2026-08-21T10:17:34-07:00穿孔IUD摘出に対する革新的な単一ポート経腹的子宮鏡手技 https://news.medxy.ai/vi/hysteroscopy-technique/Medxy AIvi2026-08-21T10:17:10-07:00Kỹ thuật nội soi buồng tử cung xuyên thành bụng một cổng: hướng tiếp cận mới để lấy bỏ IUD bị thủng https://news.medxy.ai/zh/severe-pregnancy-hypertension/Medxy AIzh2026-08-21T10:15:55-07:00严重妊娠期高血压疾病易复发：后续妊娠风险与结局评估 https://news.medxy.ai/ja/severe-pregnancy-hypertension-2/Medxy AIja2026-08-21T10:15:36-07:00重症妊娠高血圧症候群の再発を追う：将来妊娠におけるリスクと転帰の評価 https://news.medxy.ai/vi/severe-hypertension-pregnancy/Medxy AIvi2026-08-21T10:15:16-07:00Rối loạn tăng huyết áp nặng trong thai kỳ tái phát: đánh giá nguy cơ và kết cục ở những lần mang thai sau https://news.medxy.ai/zh/nek7-egfr-lenvatinib-resistance/Medxy AIzh2026-08-21T10:13:47-07:00靶向NEK7介导的EGFR磷酸化：破解肝细胞癌仑伐替尼耐药的新策略 https://news.medxy.ai/ja/overcoming-lenvatinib-resistance/Medxy AIja2026-08-21T10:13:25-07:00NEK7によるEGFRリン酸化を標的にして肝細胞癌のレンバチニブ抵抗性を克服する https://news.medxy.ai/vi/overcome-lenvatinib-resistance/Medxy AIvi2026-08-21T10:13:05-07:00Nhắm vào phosphoryl hóa EGFR do NEK7 trung gian để vượt qua kháng lenvatinib trong ung thư biểu mô tế bào gan https://news.medxy.ai/zh/cholangiocarcinoma-subtypes/Medxy AIzh2026-08-21T10:11:36-07:00多组学与机器学习揭示胆管癌分子亚型，并确定TNK1为新型治疗靶点 https://news.medxy.ai/ja/multimomics-tnk1/Medxy AIja2026-08-21T10:11:17-07:00マルチオミクスと機械学習が明らかにした胆管癌の新規分子サブタイプと治療標的 TNK1 https://news.medxy.ai/vi/multi-omics-machine-learning/Medxy AIvi2026-08-21T10:10:55-07:00Đa omics và machine learning làm rõ các phân nhóm phân tử của ung thư đường mật, xác định TNK1 là đích điều trị mới https://news.medxy.ai/zh/nsun6-pancreatic-cancer/Medxy AIzh2026-08-21T10:09:26-07:00靶向NSUN6缺失逆转胰腺癌免疫抑制：聚焦KDM5A-CCL2-巨噬细胞轴 https://news.medxy.ai/ja/65820-2/Medxy AIja2026-08-21T10:09:09-07:00NSUN6の欠損は、KDM5A-CCL2-マクロファージ軸を介して膵臓がんにおける免疫抑制を惹起する https://news.medxy.ai/vi/fix-nsun6-immune-suppression/Medxy AIvi2026-08-21T10:08:48-07:00Nhắm vào thiếu hụt NSUN6 để khắc phục ức chế miễn dịch trong ung thư tụy: Góc nhìn về trục KDM5A-CCL2-đại thực bào https://news.medxy.ai/zh/gut-lung-axis/Medxy AIzh2026-08-21T09:40:42-07:00揭开肠-肺轴之谜：肠道鞭毛蛋白通过TLR5-IL-15-ARA通路驱动多系统炎症